Global Vaccine Market Size By Type of Vaccine, By Target Population, By Channel of Distribution, By Geographic Scope And Forecast

Vaccine Market Size And Forecast

Vaccine Market size was valued at USD 46.3 Billion in 2023 and is projected to reach USD 70.4 Billion by 2030, growing at a CAGR of 8.11% during the forecast period 2024-2030.

The Vaccine Market encompasses the global trade and distribution of preventive biological substances designed to confer immunity against infectious diseases. Vaccines stimulate the body’s immune system to recognize and combat specific pathogens, thus preventing disease occurrence or reducing its severity. This market segment includes a wide array of vaccines targeting various infectious agents, such as viruses and bacteria, administered through different routes, including injection and oral ingestion. Factors driving market growth include increasing awareness of preventive healthcare, expanding vaccination programs, advancements in vaccine development technologies, and rising incidences of infectious diseases worldwide.

Global Vaccine Market Drivers

The market drivers for the Vaccine Market can be influenced by various factors. These may include

• Global Health ConcernsThe demand for vaccines is being driven by growing concerns about world health, particularly the COVID-19 pandemic and the threat of infectious illnesses like the measles, HPV, and influenza. Vaccination is becoming a top priority for governments, healthcare institutions, and individuals as a vital preventive tool to stop the spread of illness and safeguard public health.
• Technological DevelopmentsThe creation of mRNA and recombinant vector vaccines, among other developments in vaccine technology, is opening up new avenues for vaccine development and manufacturing. The vaccine market is expanding thanks to these technologies, which also provide better efficacy, scalability, and quicker development schedules.
• R&D InvestmentsGovernments, pharmaceutical corporations, and charitable organisations are making large R&D investments in vaccines, which is fueling innovation in the vaccine sector. Funding expedites the development and marketing of vaccines by supporting clinical trials, the identification of novel vaccine candidates, and the improvement of production techniques.
• Emerging Infectious DiseasesThe introduction of novel pathogens and the reappearance of preexisting ones highlight the significance of vaccine research and administration. Epidemics like COVID-19, Zika, and Ebola emphasise the importance of being ready and using preventative immunisation methods to lessen the effects of new health risks.
• Government efforts and Immunisation ProgrammesA major factor propelling market expansion is the implementation of government-led vaccination programmes and efforts that seek to improve vaccine accessibility and coverage. Mandates for vaccinations, public health campaigns, and government-funded vaccination initiatives all lead to increased vaccination rates and facilitate market growth.
• Increased Market Access and DistributionVaccine producers are seeing their market reach growing as a result of initiatives to enhance vaccine availability and distribution in underserved areas, especially in low- and middle-income nations. In order to address global health inequities and spur market growth, partnerships between governments, international organisations, and pharmaceutical corporations help ensure that vaccines are distributed fairly.
• Public Health Education and knowledgeThe demand for vaccinations is being driven by rising public knowledge of the value of immunisation in reducing disease and fostering herd immunity. Increased vaccination acceptance and uptake promotes market expansion. These factors include media attention, healthcare professional recommendations, and educational efforts.

Global Vaccine Market Restraints

Several factors can act as restraints or challenges for the Vaccine Market. These may include

• Costs associated with research and developmentCreating a novel vaccination takes a lot of time and money, and it frequently necessitates large sums of money for studies, clinical trials, and regulatory approvals. Pharmaceutical corporations may be discouraged from developing vaccines due to the high expense of research and development, especially for diseases with little commercial potential.
• Regulatory ObstaclesTo guarantee safety, efficacy, and quality, vaccines are subject to stringent regulatory inspection. The process of obtaining regulatory approvals can be time-consuming and expensive, which can postpone the release of novel vaccines and raise development costs.
• Difficulties in the Supply ChainVaccines frequently need intricate manufacturing procedures and unique storage environments, such cold chain logistics. It might be difficult to guarantee vaccine supply in isolated or resource-constrained places because of poor infrastructure, limited transit options, and inadequate storage facilities.
• Vaccine hesitationA major obstacle to the uptake of vaccines is vaccine hesitation, which is caused by false information, mistrust of medical authority, and cultural or religious views. False beliefs on the effectiveness and safety of vaccines can reduce immunisation rates, endangering the fight against diseases that can be prevented by vaccination.
• Market FragmentationThere are several producers developing vaccines for the same diseases, which leads to market fragmentation in the vaccine industry. This can result in unequal vaccination distribution, price competition, and supply constraints, especially in low-income nations where affordability is an issue.
• Intellectual Property RightsPatents and licencing agreements, among other intellectual property rights, have the potential to restrict vaccine access and impede the creation of reasonably priced substitutes. Patent protection may make it difficult for generic producers to provide less expensive vaccines, which could result in monopolies and higher costs.
• Pandemic PreparednessThe rapid development of vaccines and the introduction of novel infectious diseases, like the COVID-19 pandemic, highlight the significance of pandemic preparedness. Nonetheless, insufficient infrastructure, financial resources, and worldwide cooperation may hinder prompt reactions to epidemics, postponing the accessibility of vaccines and intensifying public health emergencies.

Global Vaccine Market Segmentation Analysis

The Global Vaccine Market is Segmented on the basis of Type of Vaccine, Target Population, Channel of Distribution, and Geography.

By Type of Vaccine

• Preventive VaccinesVaccines intended to prevent the spread of infectious diseases such the human papillomavirus (HPV), influenza, hepatitis, and measles, mumps, and rubella (MMR).
• Therapeutic Vaccines  Vaccines intended to cure or control illnesses such as allergies, autoimmune diseases, and cancer are known as therapeutic vaccines.
• Recombinant VaccinesThese vaccines create antigens against particular infections by utilising recombinant DNA technology.
• Conjugate vaccines which are used to treat conditions including meningitis and pneumococcal infections, work by combining antigens from a pathogen with a carrier protein to strengthen the immune system.

By Target Population

• Paediatric vaccinesDesigned to protect against childhood illnesses in babies, kids, and teenagers.
• Adult VaccinesThese comprise adult HPV, pneumococcal illnesses, shingles, and influenza shots.
• Vaccines for the ElderlyDesigned to protect the elderly against infections such as pneumococcal infections, herpes zoster, and influenza.
• Travel vaccinationsFor people visiting areas where endemic illnesses such as typhoid, hepatitis, and yellow fever are prevalent.

By Channel of Distribution

• Hospitals and ClinicsImmunisations are provided by medical facilities, such as clinics, hospitals, and doctor’s offices.
• Retail PharmaciesVaccines can be purchased or administered over-the-counter in retail pharmacy chains and drugstores.
• Government ProgrammesCommunity clinics, public health organisations, and national immunisation campaigns all provide vaccines.
• Internet pharmaciesFor easier access and delivery, vaccinations are increasingly being made available online.

By Geography

• North America Market conditions and demand in the United States, Canada, and Mexico.
• Europe Analysis of the Vaccine Market in European countries.
• Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa Examining market dynamics in the Middle East and African regions.
• Latin America Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Vaccine Market are

• GSK plc (UK)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi (France)
• CSL Limited (Australia)
• Johnson & Johnson Services, Inc. (US)
• AstraZeneca (UK)
• Serum Institute of India Pvt Ltd (India)
• Bharat Biotech International Limited (India)
• Sinovac Biotech Ltd. (China)
• CanSino Biologics Inc. (China)

Report Scope

Analyst’s Take

The Vaccine Market is poised for significant growth in the forecast period, driven by escalating demand for immunization against infectious diseases, particularly in developing regions with expanding healthcare infrastructure. The market is characterized by extensive research and development activities, leading to the introduction of novel vaccines targeting emerging pathogens and improvements in vaccine efficacy and safety profiles. Moreover, government initiatives, public-private partnerships, and robust investment in healthcare infrastructure are expected to further propel market expansion. However, challenges such as vaccine hesitancy, regulatory hurdles, and supply chain complexities necessitate strategic collaborations and innovative approaches to ensure widespread vaccine accessibility and uptake. Overall, the Vaccine Market presents lucrative opportunities for stakeholders, including pharmaceutical companies, biotechnology firms, and healthcare providers, to contribute to global health outcomes and drive sustainable growth in the coming years.

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.